Delivery Order SPE2DR25D2104-SPE2DR26F3VYC

<p>The Defense Logistics Agency issued a $11,536.50 delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for Gel-One 30 mg/3 mL syringes with an ultimate completion date of February 25, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $15,382 delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for Gel-One 30 mg/3 ml syringes under the company's existing DLA Troop Support Medical indefinite delivery contract.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion on February 27, 2026, and is priced on a firm fixed-price basis. No set-aside applies.</p>

<p>The Defense Logistics Agency issued a $38,455 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for supply of Gel-One 30 mg/3 mL syringes, with a completion date of March 2, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing with no set-aside.</p>

<p>The Defense Logistics Agency issued a $1,922.75 delivery order to AmerisourceBergen Drug Corp on February 13, 2026, for Gel-One 30 mg/3 mL syringes under a firm fixed-price arrangement. The order is callable against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2026. Place of performance is Conshohocken, PA. The order is scheduled for completion by March 9, 2026. No set-aside was used.</p>

On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $9,229.20 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...

<p>The Defense Logistics Agency issued a $19,227.50 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for GEL-ONE 30 mg/3 mL syringes under a firm fixed-price contract with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued without a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes valued at $7,691.00 with a firm fixed price structure. This non-competitive delivery order, issued on November 12, 2025, is scheduled for completion by December 4, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...

The Defense Logistics Agency awarded a delivery order valued at $7,691.00 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 ml syringes on October 20, 2025. This is a firm fixed price, non-set-aside contract with performance expected to be completed by November 10, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal healthcare systems. This delivery...

The Defense Logistics Agency awarded a delivery order valued at $13,459.25 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 1, 2025, with completion scheduled for December 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement...

The Defense Logistics Agency awarded a $7,691 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Gel-One 30 mg/3 ml syringes (3 ml units). This delivery order, which represents a non-set-aside competitive award, is scheduled for completion by February 20, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which...